about
Noncanonical Wnt11 inhibits hepatocellular carcinoma cell proliferation and migrationMicrosomal prostaglandin E synthase-1 promotes hepatocarcinogenesis through activation of a novel EGR1/β-catenin signaling axisGenome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemiaAstrocyte elevated gene-1 regulates hepatocellular carcinoma development and progressionMolecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advancesAcetaminophen-induced Liver Injury: from Animal Models to HumansMechanisms of hepatocellular carcinoma and challenges and opportunities for molecular targeted therapyKlotho: a tumor suppressor and modulator of the Wnt/β-catenin pathway in human hepatocellular carcinomaAEG-1/MTDH/LYRIC in liver cancerGlypican-3: a marker and a therapeutic target in hepatocellular carcinomaNovel aspects of the liver microenvironment in hepatocellular carcinoma pathogenesis and developmentAberrant regulation of Wnt signaling in hepatocellular carcinomaOxidative stress and ROS metabolism via down-regulation of sirtuin 3 expression in Cmah-null mice affect hearing lossDLC1 tumor suppressor gene inhibits migration and invasion of multiple myeloma cells through RhoA GTPase pathwayRole of DLC1 tumor suppressor gene and MYC oncogene in pathogenesis of human hepatocellular carcinoma: potential prospects for combined targeted therapeutics (review)Application of on-line nanoLC-IT-TOF in the identification of serum β-catenin complex in mice scald modelFibroblast growth factor receptor-mediated activation of AKT-β-catenin-CBP pathway regulates survival and proliferation of murine hepatoblasts and hepatic tumor initiating stem cellsThe role of the Wnt family of secreted proteins in rat oval "stem" cell-based liver regeneration: Wnt1 drives differentiationA meta-analysis of array-CGH studies implicates antiviral immunity pathways in the development of hepatocellular carcinoma.Proteomic profiling reveals the prognostic value of adenomatous polyposis coli-end-binding protein 1 in hepatocellular carcinoma.Altered {beta}-catenin accumulation in hepatocellular carcinomas of diethylnitrosamine-exposed rhesus macaquesOIP5, a target of miR-15b-5p, regulates hepatocellular carcinoma growth and metastasis through the AKT/mTORC1 and β-catenin signaling pathways.Astrocyte elevated gene-1 promotes the proliferation and invasion of breast cancer cells by activating the Wnt/β-catenin signaling pathway.Selective inhibitor of Wnt/β-catenin/CBP signaling ameliorates hepatitis C virus-induced liver fibrosis in mouse model.Enhanced Wnt Signalling in Hepatocytes is Associated with Schistosoma japonicum Infection and Contributes to Liver Fibrosis.Molecular Pathogenesis of Hepatitis-B-virus-associated Hepatocellular Carcinoma.Hypoxia-inducible factor 2 alpha is essential for hepatic outgrowth and functions via the regulation of leg1 transcription in the zebrafish embryoLiver zonation: Novel aspects of its regulation and its impact on homeostasis.Anchoring hepatic gene expression with development of fibrosis and neoplasia in a toxicant-induced fish model of liver injuryRole of Wnt/β-catenin signaling in liver metabolism and cancerSerum secreted frizzled-related protein 5 levels differentially decrease in patients with hepatitis B virus-associated chronic infection and hepatocellular carcinoma.Differential gene expression analysis of in vitro duck hepatitis B virus infected primary duck hepatocyte cultures.Cancer gene discovery in hepatocellular carcinomaCell models to study regulation of cell transformation in pathologies of retinal pigment epitheliumPostnatal liver growth and regeneration are independent of c-myc in a mouse model of conditional hepatic c-myc deletionFunctional interactions between the LRP6 WNT co-receptor and folate supplementationKrüppel-like factor 8 is a new Wnt/beta-catenin signaling target gene and regulator in hepatocellular carcinoma.The transcription factor c-Jun protects against liver damage following activated β-Catenin signaling.Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma casesFXR controls the tumor suppressor NDRG2 and FXR agonists reduce liver tumor growth and metastasis in an orthotopic mouse xenograft model.
P2860
Q24297486-AD49C370-17C0-42D1-8ED0-20247E02A8C5Q24312971-855371A9-16B3-49B6-A68C-BB1356812EB4Q24643127-F7F493C3-B366-40C7-BD1D-A55420252FD5Q24647547-B7EB7A64-9184-42A7-AD4E-78748D9D6142Q26745338-C99DFF18-8CBB-4EC7-8575-5160A85FBAE7Q26781944-3A3E93E4-0998-4A3F-BE04-E67BD7A8721AQ26798462-3BF5BD7A-118B-415B-804E-7A258301F793Q26799745-B7F931F3-66A5-4032-8091-E1956F5BEE90Q26822570-3AFF30F1-EEA0-4196-B498-15B97CB2B301Q26827487-AD351E87-D240-4485-A1C9-DD91C9A47919Q26851211-CBF084CC-E0E9-4A0C-A249-EA591800E8E6Q28079789-9E79C6F7-04BB-4D46-9C11-DCD459EFFA61Q28389690-73F109FC-7A49-48AE-B036-D2778A95E61BQ28392462-415B8665-AE95-4B41-99EE-9E5B9D470A3FQ28394917-713BA177-557C-4555-AE6D-59563D204647Q28484297-D09D1F04-3712-43EB-BD0A-2FD104C523A9Q28484908-9746AA17-B700-4196-89EC-E485E3A4BA55Q28564657-CCD5CE2A-1353-46CD-93D0-4FD2053C3C6CQ31043530-7AAE2435-B87F-4815-A1A8-68C2A1E51E15Q33378135-BE782413-F500-4A61-B53D-FD1B297A79E7Q33382038-CBF315C2-7C20-4DC8-A9AF-BA90D3125B89Q33566841-2A0614BD-2D6E-4711-8F0D-52E3E1EB78D4Q33598936-5B3C9FEB-2F3B-4215-8714-300926AEE1F0Q33669920-E083FFE8-0FC7-4991-B159-8FAE640B325CQ33671258-66D7BAA4-5A89-4FA6-AD83-6BD7C453DDF8Q33855801-5010D271-2AC2-4F53-B9A4-F5198038E578Q33856252-1AFBE27C-AD98-4C1F-B8FB-9927ED6A9807Q33886995-DADFC731-AAD3-4F42-9897-A5B6D9905124Q33894802-DACD0641-0896-4ECD-B099-D2F6FDE2F03DQ33940403-F100DC71-5E7D-4890-8120-878D46D8DB33Q33968083-9177E71F-543A-4E1C-A2A7-8AC306AEEEBCQ33969001-D924E2D8-887A-4987-AB4D-210C3E05ABA5Q34002120-15D304A5-FA01-45F0-B828-F4C68CD6266FQ34080190-6AD3F593-AEAA-4D81-8160-614DEDABA507Q34187598-7BEAD9D7-848D-436D-91A0-A88D1EB5FB85Q34275656-70DAD196-DBBF-4B44-BA1F-AFBC56E2CF32Q34326416-308F2AF7-D3B9-402D-B5BD-C5B1DB74EAE2Q34336646-311E536D-BE52-4DB5-87EC-1692A5A38824Q34383286-22F9E1E1-4127-4D4B-90AB-FE87DAA9EF14Q34440796-B2808B7E-5489-48B1-B1FD-E263AA57E41E
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
WNT/beta-catenin signaling in liver health and disease.
@ast
WNT/beta-catenin signaling in liver health and disease.
@en
type
label
WNT/beta-catenin signaling in liver health and disease.
@ast
WNT/beta-catenin signaling in liver health and disease.
@en
prefLabel
WNT/beta-catenin signaling in liver health and disease.
@ast
WNT/beta-catenin signaling in liver health and disease.
@en
P356
P1433
P1476
WNT/beta-catenin signaling in liver health and disease.
@en
P2093
Michael D Thompson
Satdarshan P S Monga
P304
P356
10.1002/HEP.21651
P407
P577
2007-05-01T00:00:00Z